OBJECTIVE: The aim of this study was to integrate European epidemiological data on patients with multiple endocrine neoplasia type 1 by creating an Italian registry of this syndrome, including clinical and genetic characteristics and therapeutic management. METHODS: Clinical, familial and genetic data of patients with multiple endocrine neoplasia type 1, diagnosed, treated, and followed-up for a mean time of 11.3 years, in 14 Italian referral endocrinological centers, were collected, over a 3-year course (2011-2013), to build a national electronic database. RESULTS: The Italian multiple endocrine neoplasia type 1 database includes 475 patients (271 women and 204 men), of whom 383 patients (80.6%) were classified as familial cases (from 136 different pedigrees), and 92 (19.4%) patients were sporadic cases. A MEN1 mutation was identified in 92.6% of familial cases and in 48.9% of sporadic cases. Four hundred thirty-six patients were symptomatic, presenting primary hyperparathyroidism, gastroenteropancreatic neuroendocrine tumors and pituitary tumors in 93, 53, and 41% of cases, respectively. Thirty-nine subjects, belonging to affected pedigrees positive for a MEN1 mutation, were asymptomatic at clinical and biochemical screening. Age at diagnosis of multiple endocrine neoplasia type 1 probands was similar for both familial and simplex cases (mean age 47.2 ± 15.3 years). In familial cases, diagnosis of multiple endocrine neoplasia type 1 in relatives of affected probands was made more than 10 years in advance (mean age at diagnosis 36.5 ± 17.6 years). CONCLUSIONS: The analysis of Italian registry of multiple endocrine neoplasia type 1 patients revealed that clinical features of Italian multiple endocrine neoplasia type 1 patients are similar to those of other western countries, and confirmed that the genetic test allowed multiple endocrine neoplasia type 1 diagnosis 10 years earlier than biochemical or clinical diagnosis.

Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database / Giusti, Francesca; Cianferotti, Luisella; Boaretto, F; Cetani, F; Cioppi, Federica; Colao, A; Davì, Mv; Faggiano, A; Fanciulli, G; Ferolla, P; Ferone, D; Fossi, Caterina; Giudici, Francesco; Gronchi, Giorgio; Loli, P; Mantero, F; Marcocci, C; Marini, Francesca; Masi, Laura; Opocher, G; Beck Peccoz, P; Persani, L; Scillitani, A; Sciortino, G; Spada, A; Tomassetti, P; Tonelli, Francesco; Brandi, MARIA LUISA. - In: ENDOCRINE. - ISSN 1559-0100. - ELETTRONICO. - (2017), pp. 1-11. [10.1007/s12020-017-1234-4]

Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database

GIUSTI, FRANCESCA;CIANFEROTTI, LUISELLA;CIOPPI, FEDERICA;FOSSI, CATERINA;GIUDICI, FRANCESCO;GRONCHI, GIORGIO;MARINI, FRANCESCA;MASI, LAURA;TONELLI, FRANCESCO;BRANDI, MARIA LUISA
2017

Abstract

OBJECTIVE: The aim of this study was to integrate European epidemiological data on patients with multiple endocrine neoplasia type 1 by creating an Italian registry of this syndrome, including clinical and genetic characteristics and therapeutic management. METHODS: Clinical, familial and genetic data of patients with multiple endocrine neoplasia type 1, diagnosed, treated, and followed-up for a mean time of 11.3 years, in 14 Italian referral endocrinological centers, were collected, over a 3-year course (2011-2013), to build a national electronic database. RESULTS: The Italian multiple endocrine neoplasia type 1 database includes 475 patients (271 women and 204 men), of whom 383 patients (80.6%) were classified as familial cases (from 136 different pedigrees), and 92 (19.4%) patients were sporadic cases. A MEN1 mutation was identified in 92.6% of familial cases and in 48.9% of sporadic cases. Four hundred thirty-six patients were symptomatic, presenting primary hyperparathyroidism, gastroenteropancreatic neuroendocrine tumors and pituitary tumors in 93, 53, and 41% of cases, respectively. Thirty-nine subjects, belonging to affected pedigrees positive for a MEN1 mutation, were asymptomatic at clinical and biochemical screening. Age at diagnosis of multiple endocrine neoplasia type 1 probands was similar for both familial and simplex cases (mean age 47.2 ± 15.3 years). In familial cases, diagnosis of multiple endocrine neoplasia type 1 in relatives of affected probands was made more than 10 years in advance (mean age at diagnosis 36.5 ± 17.6 years). CONCLUSIONS: The analysis of Italian registry of multiple endocrine neoplasia type 1 patients revealed that clinical features of Italian multiple endocrine neoplasia type 1 patients are similar to those of other western countries, and confirmed that the genetic test allowed multiple endocrine neoplasia type 1 diagnosis 10 years earlier than biochemical or clinical diagnosis.
2017
1
11
Goal 3: Good health and well-being for people
Giusti, Francesca; Cianferotti, Luisella; Boaretto, F; Cetani, F; Cioppi, Federica; Colao, A; Davì, Mv; Faggiano, A; Fanciulli, G; Ferolla, P; Ferone, D; Fossi, Caterina; Giudici, Francesco; Gronchi, Giorgio; Loli, P; Mantero, F; Marcocci, C; Marini, Francesca; Masi, Laura; Opocher, G; Beck Peccoz, P; Persani, L; Scillitani, A; Sciortino, G; Spada, A; Tomassetti, P; Tonelli, Francesco; Brandi, MARIA LUISA
File in questo prodotto:
File Dimensione Formato  
Multiple endocrine neoplasia syndrome type 1 2017.pdf

Accesso chiuso

Tipologia: Pdf editoriale (Version of record)
Licenza: Tutti i diritti riservati
Dimensione 583.33 kB
Formato Adobe PDF
583.33 kB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/1074084
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 76
  • ???jsp.display-item.citation.isi??? 60
social impact